TransEnterix (OTCMKTS:TRXDW – Get Free Report) and Nanovibronix (NASDAQ:FEED – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.
Institutional and Insider Ownership
8.2% of TransEnterix shares are held by institutional investors. Comparatively, 16.4% of Nanovibronix shares are held by institutional investors. 3.1% of TransEnterix shares are held by insiders. Comparatively, 1.4% of Nanovibronix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for TransEnterix and Nanovibronix, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TransEnterix | 0 | 0 | 0 | 0 | 0.00 |
| Nanovibronix | 1 | 0 | 0 | 0 | 1.00 |
Risk & Volatility
Profitability
This table compares TransEnterix and Nanovibronix’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TransEnterix | -2,149.15% | -83.74% | -64.94% |
| Nanovibronix | -275.12% | -24.78% | -19.24% |
Earnings and Valuation
This table compares TransEnterix and Nanovibronix”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TransEnterix | $8.53 million | 2.51 | -$154.20 million | ($4.22) | -0.04 |
| Nanovibronix | $2.69 million | 1.15 | -$3.70 million | ($41.74) | -0.07 |
Nanovibronix has lower revenue, but higher earnings than TransEnterix. Nanovibronix is trading at a lower price-to-earnings ratio than TransEnterix, indicating that it is currently the more affordable of the two stocks.
Summary
Nanovibronix beats TransEnterix on 7 of the 12 factors compared between the two stocks.
About TransEnterix
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
About Nanovibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.
